Sex Steroid Hormones and Risk of CHD in Women
NCT00006407 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-03-16
Summary
To investigate the relationship between endogenous estrogen and androgen levels and risk of coronary heart disease among postmenopausal women in the Women's Health Initiative-Observational Study (WHI-OS).
Conditions
- Cardiovascular Diseases
- Heart Diseases
- Coronary Disease
- Postmenopause
- Coronary Arteriosclerosis
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Kathryn Rexrode · Brigham and Women's Hospital
Eligibility
- Min Age
- 50 Years
- Max Age
- 79 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-09-30
- Completion
- 2004-07-31
More Related Trials
-
Hormone Replacement Therapy and Prothrombotic Variants
NCT00049933 ·Status: COMPLETED
-
Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism
NCT00565916 ·Status: TERMINATED ·Phase: NA
-
Myocardial Infarction and Non-contraceptive Estrogen Use
NCT00005185 ·Status: COMPLETED
-
Estrogen, HDL, and Coronary Heart Disease in Women
NCT00083824 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Stroke and MI in Users of Estrogen/Progestogen
NCT00005466 ·Status: COMPLETED
-
The Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in Humans
NCT07212712 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Postmenopausal Hormone Therapy in Unstable Angina
NCT00000601 ·Status: COMPLETED ·Phase: PHASE3
-
Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
NCT00000559 ·Status: COMPLETED ·Phase: PHASE3
-
CVD Risk and Health in Postmenopausal Phytoestrogen Users
NCT00000613 ·Status: COMPLETED ·Phase: PHASE2
-
Exercise and Phytoestrogens: Effect on Factors Predisposing to Cardiovascular Disease(CVD) in Postmenopausal Women
NCT01048606 ·Status: COMPLETED ·Phase: PHASE4
-
Oophorectomy, Estrogen Therapy and Cardiovascular Disease Risk in Young Women
NCT03815929 ·Status: COMPLETED ·Phase: PHASE2
-
Hostility and Pathogenic Mechanisms of Coronary Heart Disease in Women
NCT00005435 ·Status: COMPLETED
-
Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women
NCT00608062 ·Status: COMPLETED ·Phase: NA
-
Estrogen, Cytokines and Heart Failure in Women
NCT00041431 ·Status: COMPLETED ·Phase: NA
-
Cardiometabolic Consequences of the Loss of Ovarian Function
NCT06264882 ·Status: RECRUITING ·Phase: PHASE4
-
Estrogen Replacement and Atherosclerosis (ERA) in Older Women
NCT00000549 ·Status: COMPLETED ·Phase: PHASE3
-
Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women
NCT00001752 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters
NCT04453332 ·Status: UNKNOWN ·Phase: NA
-
Menopause Related Influences on Leukocyte Distribution, Monocyte Function and Platelet Reactivity
NCT05985447 ·Status: RECRUITING
-
Women's Angiographic Vitamin and Estrogen Trial (WAVE)
NCT00000555 ·Status: COMPLETED ·Phase: PHASE3
-
Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women
NCT01633814 ·Status: TERMINATED ·Phase: NA
-
Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls
NCT00005108 ·Status: COMPLETED ·Phase: PHASE2
-
Postmenopausal Estrogen/Progestin Interventions (PEPI)
NCT00000466 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Cross-sex Hormone Treatment on Cardiac Function, Myocardial and Hepatic Fat Content
NCT06245681 ·Status: RECRUITING
-
Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery
NCT00123539 ·Status: TERMINATED ·Phase: NA